SK Chemicals to work with SK Biopharm
Published: 2013-04-09 06:56:00
Updated: 2013-04-09 06:56:00
SK Chemicals announced Sunday that it signed a strategic alliance deal with SK Biopharmaceuticals Co. to spur a joint development of YKP10811, a treatment for chronic constipation under the SK Group’s new management 3.0 campaign.
Under a deal, SK Chemicals will begin phase-2 and phase-3 trials...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
